Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

ANDROGEL

BGP PHARMA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ANDROGEL in Canada?

A shortage of ANDROGEL 1% is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated October 28, 2026), but it has not started yet.

Why is ANDROGEL not available?

The reason the manufacturer reported: Demand increase for the drug.

When will ANDROGEL be available again?

The manufacturer's estimated resolution date is April 13, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products · 2 same form & route
Expected resolution~5 months remaining (estimate)
Affected strength1%
Report last updated2026-10-28
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TESTIM 1%

KNIGHT THERAPEUTICS INC.

1% · DIN 02280248

Same strengthSame dosage formSame routeNo current shortage

TARO-TESTOSTERONE GEL

TARO PHARMACEUTICALS INC

1% · DIN 02463806

Same strengthSame dosage formSame routeNo current shortage

Other Products

NATESTO

ACERUS BIOPHARMA INC

4.5% · DIN 02450550

Different strengthSame dosage formDifferent routeNo current shortage

TARO-TESTOSTERONE

TARO PHARMACEUTICALS INC

40MG · DIN 02421186

Different strengthDifferent dosage formDifferent routeNo current shortage

TESTOSTERONE ENANTHATE INJECTION, USP

HIKMA CANADA LIMITED

200MG · DIN 02536315

Different strengthDifferent dosage formDifferent routeNo current shortage

KYZATREX

HIKMA CANADA LIMITED

150MG · DIN 02562731

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2027-04-13

~5 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02245345

Strength

1%

Dosage Form

GEL

Route

TRANSDERMAL

Active Ingredient

TESTOSTERONE

Tier

Unrated

Last Updated

2026-10-28

Reason for Shortage

Demand increase for the drug.

Past Reports for This Drug

ANDROGEL has 2 shortage/discontinuation reports on file — this is one of them.